Literature DB >> 8607847

Aggregation of the inactive form of human alpha-galactosidase in the endoplasmic reticulum.

S Ishii1, R Kase, T Okumiya, H Sakuraba, Y Suzuki.   

Abstract

35S-Labeled mutant alpha-galactosidases (Q279E and R301Q) expressed in COS1 cells were detected as two forms (46-kDa protein and gel-top aggregate) on SDS-polyacrylamide gel electrophoresis under nonreducing conditions. The 46-kDa protein disappeared rapidly, but the aggregate decreased slowly. The accumulation of aggregate was observed in COS1 cells expressing either Q279E or R301Q on Western blot analysis. The aggregate was mainly recovered in the fraction extracted with 1% Triton X-100 and had no catalytic activity. The COS1 cells expressing Q279E were treated with 10 microgram/ml brefeldin A or 5 microM monensin. Treatment with brefeldin A caused a decrease in the alpha-galactosidase activity and an increase in the amount of aggregate, but the amount of aggregate did not change on monensin treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607847     DOI: 10.1006/bbrc.1996.0486

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  A revisited folding reporter for quantitative assay of protein misfolding and aggregation in mammalian cells.

Authors:  Simpson Gregoire; Inchan Kwon
Journal:  Biotechnol J       Date:  2012-06-27       Impact factor: 4.677

2.  α-Galactosidase aggregation is a determinant of pharmacological chaperone efficacy on Fabry disease mutants.

Authors:  Aleksandra Siekierska; Greet De Baets; Joke Reumers; Rodrigo Gallardo; Stanislav Rudyak; Kerensa Broersen; Jose Couceiro; Joost Van Durme; Joost Schymkowitz; Frederic Rousseau
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

3.  Cis-suppression to arrest protein aggregation in mammalian cells.

Authors:  Simpson Gregoire; Shaojie Zhang; Joseph Costanzo; Kelly Wilson; Erik J Fernandez; Inchan Kwon
Journal:  Biotechnol Bioeng       Date:  2013-10-18       Impact factor: 4.530

4.  Beta-galactosidase deficiency: an approach to chaperone therapy.

Authors:  Yoshiyuki Suzuki
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

5.  Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T).

Authors:  Hatim Y Ebrahim; Robert J Baker; Atul B Mehta; Derralynn A Hughes
Journal:  J Inherit Metab Dis       Date:  2011-10-05       Impact factor: 4.982

6.  Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.

Authors:  Brigitte A Rigat; Michael B Tropak; Justin Buttner; Ellen Crushell; Daphne Benedict; John W Callahan; Douglas R Martin; Don J Mahuran
Journal:  Mol Genet Metab       Date:  2012-06-19       Impact factor: 4.797

7.  Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.

Authors:  Michael J Lumb; Graeme M Birdsey; Christopher J Danpure
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

8.  The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines.

Authors:  E R Benjamin; J J Flanagan; A Schilling; H H Chang; L Agarwal; E Katz; X Wu; C Pine; B Wustman; R J Desnick; D J Lockhart; K J Valenzano
Journal:  J Inherit Metab Dis       Date:  2009-04-18       Impact factor: 4.982

9.  Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis.

Authors:  Junichiro Matsuda; Osamu Suzuki; Akihiro Oshima; Yoshie Yamamoto; Akira Noguchi; Kazuhiro Takimoto; Masayuki Itoh; Yuji Matsuzaki; Yosuke Yasuda; Seiichiro Ogawa; Yuko Sakata; Eiji Nanba; Katsumi Higaki; Yoshimi Ogawa; Lika Tominaga; Kousaku Ohno; Hiroyuki Iwasaki; Hiroshi Watanabe; Roscoe O Brady; Yoshiyuki Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

10.  Techniques for Monitoring Protein Misfolding and Aggregation in Vitro and in Living Cells.

Authors:  Simpson Gregoire; Jacob Irwin; Inchan Kwon
Journal:  Korean J Chem Eng       Date:  2012-06       Impact factor: 3.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.